Interaction of mitoxantrone, as an anticancer drug, with chromatin proteins, core histones and H1, in solution.

[1]  Azra Rabbani-Chadegani,et al.  Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins , 2009, Journal of Biomedical Science.

[2]  A. Rabbani,et al.  Affinity of anticancer drug, daunomycin, to core histones in solution: comparison of free and cross—linked proteins , 2007, Acta Pharmacologica Sinica.

[3]  Ying Ma,et al.  Interaction of anticancer drug mitoxantrone with DNA analyzed by electrochemical and spectroscopic methods. , 2005, Biophysical chemistry.

[4]  J. Ausió,et al.  Binding of antitumor antibiotic daunomycin to histones in chromatin and in solution. , 2004, Biochemistry.

[5]  Richard J. White,et al.  Development of mitoxantrone , 2004, Investigational New Drugs.

[6]  S. J. Zargar,et al.  The effects of daunomycin antibiotic on histone H(1): thermal denaturation and fluorescence spectroscopy studies. , 2000, International journal of biological macromolecules.

[7]  J. Azizkhan,et al.  A comparison of DNA-binding drugs as inhibitors of E2F1- and Sp1-DNA complexes and associated gene expression. , 1998, Biochemistry.

[8]  F. Zunino,et al.  Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II. , 1993, Biochemistry.

[9]  B. Wang,et al.  The nucleosomal core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-handed superhelix. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Faulds,et al.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. , 1991, Drugs.

[11]  S. Martin,et al.  Alpha‐helix in the carboxy‐terminal domains of histones H1 and H5. , 1988, The EMBO journal.

[12]  W. Wilson,et al.  Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids. , 1985, Biochemistry.

[13]  E. Uyeki,et al.  Cellular uptake and inhibition of DNA synthesis by dihydroxyanthraquinone and two analogues. , 1983, Cancer research.

[14]  L. Franco,et al.  Fluorescence of histones H1. A tyrosinate-like fluorescence emission in Ceratitis capitata H1 at neutral pH values. , 1983, The Journal of biological chemistry.

[15]  P. G. Hartman,et al.  The structure of histone H1 and its location in chromatin , 1980, Nature.

[16]  G. Goodwin,et al.  Studies on the tissue specificity of the high-mobility-group non-histone chromosomal proteins from calf. , 1978, The Biochemical journal.

[17]  P. Cary,et al.  Studies on the role and mode of operation of the very-lysine-rich histone H1 (F1) in eukaryote chromatin. The conformation of histone H1. , 1975, European journal of biochemistry.

[18]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[19]  D. Baumann.  [New drugs. 3]. , 1970, Pharmazeutische Praxis.

[20]  E. W. Johns.  Studies on histones. 7. Preparative methods for histone fractions from calf thymus. , 1964, The Biochemical journal.